Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux

World Journal of Gastroenterology

Volumn 13, Issue 11, 2007, Pages 1706-1710

  Sharma, Bhavneesh ^a   Sharma, Manisha ^a   Daga, Mradul Kumar ^b   Sachdev, Gopal Krishnan ^b   Bondi, Elliott ^a  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

^b MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Antireflux therapy; Asthma; Gastroesophageal reflux disease; Omeprazole; Prokinetic; Reflux

Indexed keywords

DOMPERIDONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; OMEPRAZOLE; PLACEBO; SALBUTAMOL;

ADULT; AGGRESSION; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESOPHAGUS PH; FEMALE; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MYALGIA; NIGHT; OUTCOME ASSESSMENT; PATIENT MONITORING; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SPIROMETRY; STEVENS JOHNSON SYNDROME; SYMPTOMATOLOGY; THROMBOCYTOPENIA; URTICARIA;

EID: 34248148660     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i11.1706     Document Type: Article

References (40)

1. Richter JE. Gastroesophageal reflux disease and asthma: the two are directly related. Am J Med 2000; 108 Suppl 4a: 153S-158S
2. Wright RA, Miller SA, Corsello BF. Acid-induced esophago-bronchial-cardiac reflexes in humans. Gastroenterology 1990; 99: 71-73
3. Fischer A, McGregor GP, Saria A, Philippin B, Kummer W. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest 1996; 98: 2284-2291
4. Vincent D, Cohen-Jonathan AM, Leport J, Merrouche M, Geronimi A, Pradalier A, Soule JC. Gastro-oesophageal reflux prevalence and relationship with bronchial reactivity in asthma. Eur Respir J 1997; 10: 2255-2259
5. Cuttitta G, Cibella F, Visconti A, Scichilone N, Bellia V, Bonsignore G. Spontaneous gastroesophageal reflux and airway patency during the night in adult asthmatics. Am J Respir Crit Care Med 2000; 161: 177-181
6. Tuchman DN, Boyle JT, Pack AI, Scwartz J, Kokonos M, Spitzer AR, Cohen S. Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology 1984; 87: 872-881
7. Jack CI, Calverley PM, Donnelly RJ, Tran J, Russell G, Hind CR, Evans CC. Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax 1995; 50: 201-204
8. Harding SM. GERD, airway disease, and the mechanisms of interaction. In: Stein MR. Lung biology in health and disease, volume 129: gastroesophageal disease and airway disease. New York: Marcel Dekker, 1999: 139-178
9. Nagel RA, Brown P, Perks WIH, Wilson RS, Kerr GD. Ambulatory pH monitoring of gastro-oesophageal reflux in "morning dipper" asthmatics. BMJ 1988; 297: 1371-1373
10. Sontag SJ, O'Connell S, Khandelwal S, Miller T, Nemchausky B, Schnell TG, Serlovsky R. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990; 99: 613-620
11. Harding SM, Guzzo MR, Richter JE. 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest 1999; 115: 654-659
12. Kiljander TO, Salomaa ER, Hietanen EK, Terho EO. Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole. Chest 1999; 116: 1257-1264
13. Ford GA, Oliver PS, Prior JS, Butland RJ, Wilkinson SP. Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: a placebo-controlled cross-over study. Postgrad Med J 1994; 70: 350-354
14. Meier JH, McNally PR, Punja M, Freeman SR, Sudduth RH, Stocker N, Perry M, Spaulding HS. Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study. Dig Dis Sci 1994; 39: 2127-2133
15. Teichtahl H, Kronborg IJ, Yeomans ND, Robinson P. Adult asthma and gastro-oesophageal reflux: the effects of omeprazole therapy on asthma. Aust N Z J Med 1996; 26: 671-676
16. Levin TR, Sperling RM, McQuaid KR. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux. Am J Gastroenterol 1998; 93: 1060-1063
17. Boeree MJ, Peters FT, Postma DS, Kleibeuker JH. No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux. Eur Respir J 1998; 11: 1070-1074
18. Harmanci E, Entok E, Metintas M, Vardareli E, Elbek O. Gastroesophageal reflux in the patients with asthma. Allergol Immunopathol (Madr) 2001; 29: 123-128
19. Jiang SP, Liang RY, Zeng ZY, Liu QL, Liang YK, Li JG. Effects of antireflux treatment on bronchial hyper-responsiveness and lung function in asthmatic patients with gastroesophageal reflux disease. World J Gastroenterol 2003; 9: 1123-1125
20. Calabrese C, Fabbri A, Areni A, Scialpi C, Zahlane D, Di Febo G. Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy. World J Gastroenterol 2005; 11: 7657-7660
21. Kiljander TO, Harding SM, Field SK, Stein MR, Nelson HS, Ekelund J, Illueca M, Beckman O, Sostek MB. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2006; 173: 1091-1097.
22. Littner MR, Leung FW, Baud ED 2nd, Huang B, Samra NK. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 2005, 128: 1128-1135
23. Gopal B, Singhal P, Gaur SN. Gastroesophageal reflux disease in bronchial asthma and the response to omeprazole. Asian Pac J Allergy Immunol 2005; 23: 29-34
24. Eryuksel E, Dogan M, Golabi P, Sehitoglu MA, Celikel T. Treatment of laryngopharyngeal reflux improves asthma symptoms in asthmatics. J Asthma 2006; 43: 539-542
25. Field SK, Sutherland LR. Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux? a critical review of the literature. Chest 1998; 114: 275-283
26. Jamieson JR, Stein HJ, DeMeester TR, Bonavina L, Schwizer W, Hinder RA, Albertucci M. Ambulatory 24-h esophageal pH monitoring: normal values optimal thresholds, specificity sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 1102-1111
27. Ayres JG, Campbell LM. A controlled assessment of an asthma self-management plan involving a budesonide dose regimen. OPTIONS Research Group. Eur Respir J 1996; 9: 886-892
28. Robinson DS, Campbell D, Barnes PJ. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. Lancet 2001; 357: 2007-2011
29. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337: 1405-1411
30. Harding SM, Richter JE, Guzzo MR, Schan CA, Alexander RW, Bradley LA. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 1996; 100: 395-405
31. Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 2000;: CD001496
32. Harding SM. Gastroesophageal reflux: a potential asthma trigger. Immunol Allergy Clin North Am 2005; 25: 131-148
33. Mehta DI. Importance of non-acid reflux in asthma in children. Available from:http://clinicaltrials.gov/show/NCT00200980
34. Tytgat GN, Janssens J, Reynolds JC, Wienbeck M. Update on the pathophysiology and management of gastro-oesophageal reflux disease: the role of prokinetic therapy. Eur J Gastroenterol Hepatol 1996; 8: 603-611
35. Blum AL, Adami B, Bouzo MH, Brandstatter G, Fumagalli I, Galmiche JP, Hebbeln H, Hentschel E, Huttemann W, SChutz E. Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists. Dig Dis Sci 1993; 38: 551-560
36. McCallum RW, Fink SM, Winnan GR, Avella J, Callachan C. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial. Am J Gastroenterol 1984; 79: 165-172
37. Takahashi T, Kurosawa S, Wiley JW, Owyang C. Mechanism for the gastrokinetic action of domperidone. In vitro studies in guinea pigs. Gastroenterology 1991; 101: 703-710
38. De Loore I, Van Ravensteyn H, Ameryckx L. Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide. Postgrad Med J 1979; 55: Suppl 1: 40-42
39. Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995; 333: 1106-1110
40. Sekiguchi T, Nishioka T, Matsuzaki T, Sugiyama M, Kusano M, Horikoshi T, Toki M, Ohwada T, Kobayashi S. Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis. Gastroenterol Jpn 1991; 26: 137-144